Concepedia

Sujatro Chakladar

SC

Statistics

Publications

10

Citations

1.1K

H-Index

10

Active since

2015

Affiliations

Eli Lilly (United States)(Current)

University of Illinois Chicago

University of North Carolina at Chapel Hill

University of Minnesota

University of Bristol

Sujatro Chakladar is an author at Eli Lilly (United States) specializing in pharmacotherapy, medicine, and clinical pharmacology.

Publications per year

2015–2025

10

Publications

10

Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity

Atul Malhotra, Ronald R. Grunstein, Ingo Fietze et al. · New England Journal of Medicine · 2024 · 648 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Reducing the Blood Pressure–Related Burden of Cardiovascular Disease: Impact of Achievable Improvements in Blood Pressure Prevention and Control

Shakia T. Hardy, Laura R. Loehr, Kenneth R. Butler et al. · Journal of the American Heart Association · 2015 · 221 citations · Full text

Medicine, Cardiology, Preventive Medicine +17

Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial

Atul Malhotra, Josef Bednařík, Sujatro Chakladar et al. · Contemporary Clinical Trials · 2024 · 73 citations · Full text

Medicine, Pharmacotherapy, Clinical Pharmacology +16

Heterogeneity in Blood Pressure Transitions Over the Life Course

Shakia T. Hardy, Katelyn M. Holliday, Sujatro Chakladar et al. · JAMA Cardiology · 2017 · 41 citations · Full text

Public Health, Cardiology, Population Health Sciences +17

Efficacy and safety of baricitinib in patients with COVID-19 infection: Results from the randomised, double-blind, placebo-controlled, parallel-group COV-BARRIER phase 3 trial

Vincent C. Marconi, Athimalaipet V Ramanan, Stephanie de Bono et al. · medRxiv · 2021 · 36 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

1–5 of 10